四种非洲国家儿童肺结核尿液LAM检测准确性比较
该横断面研究在冈比亚、马里、尼日利亚和坦桑尼亚四国儿童结核门诊连续纳入415例疑似肺结核儿童,配对检测冻存尿标本中FujiLAM与AlereLAM的诊断准确性。以微生物学参考标准,FujiLAM敏感性64·9%高于AlereLAM的30·7%,特异性相近;FujiLAM可能为儿童结核快速诊断带来增量价值。
要点
- FujiLAM对确诊结核敏感性64·9%,高于AlereLAM的30·7%
- 两者特异性相近,FujiLAM为83·8%、AlereLAM为87·8%
- 采用复合参考标准时两种检测敏感性均明显下降
核心结论
- 与AlereLAM相比,FujiLAM敏感性更高、特异性相似,可能为儿童结核快速诊断带来增量价值。
研究设计与样本
- 横断面研究,2017年7月1日至2018年12月1日从四国儿童结核门诊连续纳入415例15岁以下疑似肺结核儿童, thaw冻存尿样行FujiLAM与AlereLAM检测,采用双变量随机效应荟萃分析估计敏感性及特异性。
主要发现
- 63例(15%)为确诊结核,113例(27%)为未确诊结核,239例(58%)不太可能患结核,61例HIV阳性(患病率15%)。
- 以微生物学参考标准,FujiLAM敏感性64·9%(95%CI 43·7-85·2;63份确诊样本中40份阳性),AlereLAM敏感性30·7%(8·6-61·6;63份中19份)。
- 以微生物学参考标准,FujiLAM特异性83·8%(95%CI 76·5-89·4;352份未确诊及不太可能样本中297份阴性),AlereLAM特异性87·8%(79·0-93·7;352份中312份)。
- 以复合参考标准,FujiLAM敏感性32·9%(95%CI 24·6-41·9;176份确诊及未确诊样本中58份阳性),AlereLAM敏感性20·2%(12·3-29·4;176份中36份)。
- 以复合参考标准,FujiLAM特异性83·3%(95%CI 71·8-91·7;239份不太可能样本中202份阴性),AlereLAM特异性90·0%(81·6-95·6;239份中216份)。
关键数值与推荐
- 确诊结核定义采用微生物学参考标准;未确诊结核与确诊结核合并构成复合参考标准。
- 微生物学参考标准下FujiLAM敏感性64·9%、特异性83·8%;AlereLAM敏感性30·7%、特异性87·8%。
临床怎么用
- 在疑似肺结核儿童中,尿液FujiLAM可作为非痰标本的快速辅助检测,但需结合临床及微生物学结果判读。
- 对微生物学确诊困难的儿童,需注意复合参考标准下两种LAM检测敏感性均较低。
局限性
- 为横断面研究,使用冻存尿样 thaw后检测,可能影响结果外推。
- 确证结核病例数有限(63例),敏感性估计的95%CI较宽。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A sensitive and specific non-sputum-based test would be groundbreaking for the diagnosis of childhood tuberculosis. We assessed side by side the diagnostic accuracy of the urine-based lipoarabinomannan assays Fujifilm SILVAMP TB LAM (FujiLAM) and Alere Determine TB LAM Ag (AlereLAM) for detection of childhood tuberculosis. METHODS: In this cross-sectional study, we tested urine samples from children younger than 15 years with presumed pulmonary tuberculosis. Children were consecutively recruited from four dedicated outpatient childhood tuberculosis clinics in The Gambia, Mali, Nigeria, and Tanzania. Biobanked urine samples were thawed and tested using FujiLAM and AlereLAM assays. We measured diagnostic performance against a microbiological reference standard (confirmed tuberculosis) and a composite reference standard (confirmed and unconfirmed tuberculosis). Sensitivity and specificity were estimated with bivariate random-effects meta-analyses. FINDINGS: Between July 1, 2017, and Dec 1, 2018, we obtained and stored urine samples from 415 children. 63 (15%) children had confirmed tuberculosis, 113 (27%) had unconfirmed tuberculosis, and 239 (58%) were unlikely to have tuberculosis. 61 children were HIV-positive (prevalence 15%). Using the microbiological reference standard, the sensitivity of FujiLAM was 64·9% (95% CI 43·7-85·2; positive in 40 of 63 confirmed samples) and the sensitivity of AlereLAM was 30·7% (8·6-61·6; 19 of 63). The specificity of FujiLAM was 83·8% (95% CI 76·5-89·4; negative in 297 of 352 unconfirmed and unlikely samples) and the specificity of AlereLAM was 87·8% (79·0-93·7; 312 of 352). Against the composite reference standard, both assays had decreased sensitivity; the sensitivity of FujiLAM was 32·9% (95% CI 24·6-41·9; positive in 58 of 176 confirmed and unconfirmed samples) and the sensitivity of AlereLAM was 20·2% (12·3-29·4; 36 of 176). The specificity of FujiLAM was 83·3% (95% CI 71·8-91·7; negative in 202 of 239 unlikely samples) and the specificity of AlereLAM was 90·0% (81·6-95·6; 216 of 239). INTERPRETATION: By comparison with AlereLAM, FujiLAM showed higher sensitivity and similar specificity. FujiLAM could potentially add value to the rapid diagnosis of tuberculosis in children. FUNDING: German Federal Ministry of Education and Research, the Global Health Innovative Technology Fund, the UK Research and Innovation Global Challenges Research Fund, and the UK Medical Research Council.
引用
- Nkereuwem E, Togun T, Gomez MP, et al. Comparing accuracy of lipoarabinomannan urine tests for diagnosis of pulmonary tuberculosis in children from four African countries: a cross-sectional study. Lancet Infect Dis. 2020. PMID: 33316214. doi:10.1016/S1473-3099(20)30598-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。